Clinical trial
Defining the Optimal Hormonal Replacement Therapy in Turner Syndrome
NCT00134745 · Line Cleemann, Other · Completed
Key facts
| NCT number | NCT00134745 |
|---|---|
| Title | Defining the Optimal Hormonal Replacement Therapy in Turner Syndrome |
| Official title | The Growth of Genitalia Interna and the Bone Mineralization Under Hormonal Replacement Therapy and the Presence of Aortic Root Dilatation in Girls With Turner Syndrome |
| Lead sponsor | Line Cleemann, Other |
| Collaborators | Novo Nordisk A/S Industry The County of Frederiksborg The foundation of Kaptajnløjtnant Harald Jensen and Wife The foundation of Mrs. Olga Bryde The foundation of Mr. Ivan Nielsen |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Turner Syndrome |
| Intervention type | Drug |
| Interventions | estradiol |
| Enrollment | 43 |
| Start date | Jun 1, 2005 |
| Primary completion | Mar 1, 2013 |
| Completion | Mar 1, 2013 |
| First posted | Aug 25, 2005 |
| Last update posted | Jun 14, 2013 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: